thiazoles has been researched along with Vascular Malformations in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garreta Fontelles, G; Grande Moreillo, C; Pardo Pastor, J | 1 |
| Dubois, J; Facundo, GB; Gavra, P; Kleiber, N; Lapointe, C; Remy, A; Théorêt, Y; Tran, TH; Winikoff, R | 1 |
| Diness, BR; Frevert, S; Harder, KM; Hjortshøj, TD; Hove, H; Jørgensen, FS; Karstensen, HG; Schönewolf-Greulich, B | 1 |
| Amiel, J; Berteloot, L; Blanc, E; Blanc, T; Boccara, O; Boddaert, N; Bole-Feysot, C; Broissand, C; Canaud, G; Chaussain, C; Cormier-Daire, V; Duong, JP; Grenier, N; Guibaud, L; Hoguin, C; Johnson, SC; Joly, D; Knebelmann, B; Ladraa, S; Laroche-Raynaud, C; Legendre, C; Lyonnet, S; Magassa, S; Martinez, F; Merville, P; Michot, C; Pannier, S; Picard, A; Rabia, SH; Sadoine, J; Sarnacki, S; Slimani, L; Soupre, V; Terzi, F; Venot, Q; Yamaguchi, J | 1 |
| Delgado, C; Díaz, M; Lizarraga, R; López Gutiérrez, JC; Martínez Urrutia, MJ; Miguel, M; Triana, P | 1 |
| Boon, LM; Eklund, L; Godfraind, C; Helaers, R; Kangas, J; Limaye, N; Mendola, A; Schlögel, MJ; Vikkula, M | 1 |
1 trial(s) available for thiazoles and Vascular Malformations
| Article | Year |
|---|---|
Targeted therapy in patients with PIK3CA-related overgrowth syndrome.
Topics: Adult; Animals; Child; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Female; Heart Failure; HeLa Cells; Humans; Lipoma; Male; Mice; Molecular Targeted Therapy; Musculoskeletal Abnormalities; Nevus; Phenotype; Scoliosis; Sirolimus; Syndrome; Thiazoles; Vascular Malformations; Vascular Neoplasms | 2018 |
5 other study(ies) available for thiazoles and Vascular Malformations
| Article | Year |
|---|---|
Alpelisib to treat CLOVES syndrome, a member of the PIK3CA-related overgrowth syndrome spectrum.
Topics: Catalytic Domain; Class I Phosphatidylinositol 3-Kinases; Growth Disorders; Humans; Lipoma; Musculoskeletal Abnormalities; Mutation; Nevus; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Syndrome; Thiazoles; Vascular Malformations | 2022 |
Repurposing alpelisib, an anti-cancer drug, for the treatment of severe TIE2-mutated venous malformations: Preliminary pharmacokinetics and pharmacodynamic data.
Topics: Antineoplastic Agents; Blood Coagulation Disorders; Child; Drug Repositioning; Humans; Quality of Life; Thiazoles; Vascular Malformations | 2022 |
Early diagnosis enabling precision medicine treatment in a young boy with PIK3R1-related overgrowth.
Topics: Child; Class I Phosphatidylinositol 3-Kinases; Class Ia Phosphatidylinositol 3-Kinase; Early Diagnosis; Female; Humans; Male; Musculoskeletal Abnormalities; Mutation; Precision Medicine; Pregnancy; Syndrome; Thiazoles; Transcription Factors; Vascular Malformations | 2022 |
Alpelisib Treatment for Genital Vascular Malformation in a Patient with Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Spinal/Skeletal Anomalies and/or Scoliosis (CLOVES) Syndrome.
Topics: Adolescent; Class I Phosphatidylinositol 3-Kinases; Female; Genitalia, Female; Humans; Lipoma; Musculoskeletal Abnormalities; Nevus; Protein Kinase Inhibitors; Thiazoles; Vascular Malformations | 2019 |
Somatic Activating PIK3CA Mutations Cause Venous Malformation.
Topics: Alleles; Class I Phosphatidylinositol 3-Kinases; Gene Expression Regulation; Gene Frequency; Genetic Association Studies; High-Throughput Nucleotide Sequencing; Human Umbilical Vein Endothelial Cells; Humans; Mutation; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Receptor, TIE-2; Signal Transduction; Thiazoles; Transfection; Vascular Malformations; Veins | 2015 |